Investing.com - Harpoon Therapeutics reported on Monday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Harpoon Therapeutics announced earnings per share of $-0.35 on revenue of $13.62M. Analysts polled by Investing.com EPS of $-0.56 on revenue of $5.56M.
Harpoon Therapeutics 's are down 30% and is trading at $0.79 , still down 90.37% from its 52 week high of $8.20 set on Tuesday, January 4, 2022.
Harpoon Therapeutics follows other major Healthcare sector earnings this month
Harpoon Therapeutics's report follows an earnings beat by J&J on Tuesday, October 18, 2022, who reported EPS of $2.55 on revenue of $23.79B, EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.98 on revenue of $6.94B, for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar